JG
Jefferies Group Portfolio holdings
AUM
$3.42B
1-Year Return
1.45%
This Quarter Return
+3.13%
1 Year Return
-1.45%
3 Year Return
+33.54%
5 Year Return
+41.04%
10 Year Return
–
AUM
$5.37B
AUM Growth
+$1.21B
(+29%)
Cap. Flow
+$661M
Cap. Flow
% of AUM
12.3%
Top 10 Holdings %
Top 10 Hldgs %
35.59%
Holding
1,481
New
322
Increased
279
Reduced
235
Closed
357
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$597M |
| 2 |
Avis
CAR
|
$308M |
| 3 |
Invesco QQQ Trust
QQQ
|
$214M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$93.9M |
| 5 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
$55.1M |
Top Sells
Sector Composition
| 1 | Industrials | 11.79% |
| 2 | Healthcare | 10.37% |
| 3 | Technology | 9% |
| 4 | Consumer Discretionary | 7.02% |
| 5 | Financials | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Occidental Petroleum
OXY
$45.2B
| $6.14M | 0.04% |
211,716
+70,216
| +50% | +$2.04M |
|
152
Edwards Lifesciences
EW
$47.5B
| $6.13M | 0.04% |
47,300
-42,500
| -47% | -$5.51M |
|
153
Marsh & McLennan
MMC
$100B
| $6.08M | 0.04% |
+35,000
| New | +$6.08M |
|
154
Emerson Electric
EMR
$74.6B
| $6.05M | 0.04% |
+65,100
| New | +$6.05M |
|
155
TJX Companies
TJX
$155B
| $6.04M | 0.04% |
+79,500
| New | +$6.04M |
|
|
NUAN
156
DELISTED
Nuance Communications, Inc.
NUAN
| $5.98M | 0.04% |
108,175
-15,668
| -13% | -$867K |
|
157
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.5B
| $5.95M | 0.03% |
54,575
-514,425
| -90% | -$56.1M |
|
158
Constellation Brands
STZ
$26.2B
| $5.82M | 0.03% |
23,209
+6,345
| +38% | +$1.59M |
|
159
Chubb
CB
$111B
| $5.82M | 0.03% |
+30,100
| New | +$5.82M |
|
160
ON Semiconductor
ON
$20.1B
| $5.78M | 0.03% |
85,090
+35,090
| +70% | +$2.38M |
|
|
XYZ
161
Block, Inc.
XYZ
$45.7B
| $5.78M | 0.03% |
35,766
+16,117
| +82% | +$2.6M |
|
162
Kyndryl
KD
$7.57B
| $5.73M | 0.03% |
+316,672
| New | +$5.73M |
|
|
SJI
163
DELISTED
South Jersey Industries, Inc.
SJI
| $5.68M | 0.03% |
+217,500
| New | +$5.68M |
|
164
EQT Corp
EQT
$32.2B
| $5.63M | 0.03% |
+257,943
| New | +$5.63M |
|
165
Waters Corp
WAT
$18.2B
| $5.59M | 0.03% |
+15,000
| New | +$5.59M |
|
|
NVRO
166
DELISTED
NEVRO CORP.
NVRO
| $5.53M | 0.03% |
68,197
+46,000
| +207% | +$3.73M |
|
|
SCLE
167
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
| $5.5M | 0.03% |
+552,908
| New | +$5.5M |
|
168
Alnylam Pharmaceuticals
ALNY
$59.2B
| $5.42M | 0.03% |
31,959
+18,515
| +138% | +$3.14M |
|
|
SPLK
169
DELISTED
Splunk Inc
SPLK
| $5.35M | 0.03% |
46,222
+37,915
| +456% | +$4.39M |
|
170
Arch Capital
ACGL
$34.1B
| $5.31M | 0.03% |
119,496
-80,504
| -40% | -$3.58M |
|
171
Comcast
CMCSA
$125B
| $5.31M | 0.03% |
105,500
-139,500
| -57% | -$7.02M |
|
|
MRNS
172
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $5.22M | 0.03% |
439,764
| – | – |
|
173
Patterson-UTI
PTEN
$2.18B
| $5.2M | 0.03% |
615,926
+520,326
| +544% | +$4.4M |
|
174
Hanesbrands
HBI
$2.27B
| $5.08M | 0.03% |
303,910
+235,130
| +342% | +$3.93M |
|
175
Regeneron Pharmaceuticals
REGN
$60.8B
| $5.08M | 0.03% |
8,039
-161
| -2% | -$102K |
|